
OutSee raises £2.5m and partners with o2h discovery
Genomic and drug discovery company OutSee has closed a £2.5 million ($3.4 million) seed funding round and partnered with contract research organisation o2h discovery to develop a lead drug target candidate. The partnership aims to launch a collaborative drug discovery programme for OutSee’s lead target candidate, identified through the company’s genomic target discovery and precision medicine… Read More













